Skip to main content

A third geroscience summit on the horizon

I’m very pleased to report that only seven short years after taking our first steps in geroscience, we’re now ready to expand the reach of the field into new areas with a third Summit on Geroscience. While the concept of geroscience has been well accepted within the aging biology research community, the goal of the upcoming Summit is to extend our reach into new areas of scientific endeavor and to involve new participants, including disease advocates and policymakers.
Felipe Sierra
Felipe SIERRA,
Scientific Executive,
Division of Aging Biology (DAB)
.
8 Comments

NIA launches unique challenge competition for Alzheimer's care software

Are you up for a challenge? Then check out the Improving Care for People with Alzheimer’s Disease and Related Dementias Using Technology (iCare-AD/ADRD) Challenge. Submissions opened on October 1, 2018 for NIA’s first Eureka prize competition. Applicants can compete for up to $250,000 in cash prizes for their solutions.

Dr. Dawn Beraud
Dawn BERAUD,
Health Science Policy Analyst,
Office of the Director (OD)
.
Picture of Dr. Partha Bhattacharyya
Partha BHATTACHARYYA,
Program Director,
Division of Behavioral and Social Research (DBSR)
.

NCRAD poised for major expansion

Infrastructure may seem like an odd word to use when thinking about research into Alzheimer’s disease. We want to see clinical trial results. We want answers on the basic mechanisms. We want prevention measures. And we want them all now! Infrastructure may seem less exciting, but it’s absolutely necessary to achieve our goals for research in Alzheimer’s disease. That’s why NIA has substantially increased the grant award to the Indiana University School of Medicine for the National Centralized Repository for Alzheimer’s Disease and Related Dementias (NCRAD).
Nina Silverberg
Nina SILVERBERG,
Program Director, Alzheimers Disease Center,
Division of Neuroscience (DN)
.

Good news! Increased pay lines ahead!

I have good news for you! We’re giving 6 percent back to all the competing awards that we cut by an average of 18 percent in 2018. We will also be working from an average cut of 12 percent for awards we make in FY 2019. We’ve also expanded our general pay line to the 23rd percentile.
Dr. Robin Barr
Robin BARR,
Director, DEA,
Division of Extramural Activities (DEA)
.
4 Comments

CALERIE Network aims to inspire, support new studies

The first study to specifically focus on the effects of sustained caloric restriction (CR) in humans—CALERIE (Comprehensive Assessment of the Long-term Effects of Reducing Intake of Energy)—collected a trove of biosamples and data. CALERIE investigators are now aiming to facilitate new studies and analyses that will take advantage of these resources.
Giovanna Zappala
Giovanna ZAPPALA,
Health Scientist Administrator,
Division of Geriatrics and Clinical Gerontology (DGCG)
.

Save the Date! Workshop on osteoporotic drugs and prevention

Sticks and stones aren’t the only things that can break your bones—osteoporosis is also a main cause. In fact, 50 percent of women and 20 percent of men over age 50 will break a bone because of low bone mass or poor bone quality. To better understand current knowledge gaps in osteoporosis research and identify future needs in using osteoporosis drugs, NIH is hosting a Pathways to Prevention (P2P) Workshop: Appropriate Use of Drug Therapies for Osteoporotic Fracture Prevention.
Dr. Lyndon Joseph
Lyndon JOSEPH,
Health Scientist Administrator,
Division of Geriatrics and Clinical Gerontology (DGCG)
.

Symposium celebrates open science, launches new data platform

It was great to see so many of you at the Alzheimer’s Association International Conference last month! I was thrilled to catch up with colleagues, attend the special events, and learn about many new Alzheimer’s research findings. In case you missed it, NIA and the Alzheimer’s Association hosted a pre-conference symposium: “Enabling Precision Medicine for Alzheimer’s Disease Through Open Science.”
Suzana Petanceska
Suzana PETANCESKA,
Program Officer,
Division of Neuroscience (DN)
.

Together we make the difference in Alzheimer's and related dementias research: NIH's FY 2020 bypass budget and progress report

On Monday, July 30, I presented, on behalf of NIH Director Dr. Francis Collins, the Fiscal Year 2020 NIH Professional Judgment Budget for Alzheimer’s Disease and Related Dementias at the meeting of the HHS Secretary’s Advisory Council on Alzheimer’s Research, Care, and Services. The estimate—commonly referred to as a Bypass Budget—is based on scientific opportunities that NIH could pursue to achieve the research goal of the National Plan to Address Alzheimer’s Disease—to prevent and effectively treat Alzheimer’s disease by 2025. 
Dr. Richard Hodes
Richard HODES,
Director,
Office of the Director (OD)
.

Watch for NIA at AAIC in the Windy City!

NIA staff are gearing up for the annual Alzheimer’s Association International Conference (AAIC) 2018, taking place this year in Chicago, July 22-26. AAIC is dedicated to advancing dementia science, and we’re looking forward to attending alongside thousands from the Alzheimer’s community.
Eliezer Masliah
Eliezer MASLIAH,
Director,
Division of Neuroscience (DN)
.